Costa Verde Capital

Costa Verde Capital is a private investment firm primarily focused on the life sciences, biotechnology, and healthcare sectors. The firm was co-founded by John F. Milligan, PhD, the former President and Chief Executive Officer of Gilead Sciences, bringing significant industry leadership and operational expertise to its investment strategy. Costa Verde Capital provides strategic capital to both private and public companies, often focusing on transformative therapies and medical innovations. The firm acts as a value-add partner, leveraging its deep network and experience in drug development and commercialization to support its portfolio companies. It typically engages in selective investments where its industry-specific insights can accelerate the growth of high-impact healthcare solutions.